Search Results - "Soh, Thomas I P"

Correlation of aldo‐ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients by Voon, Pei Jye, Yap, Hui Ling, Ma, Cho‐Yee‐Thu, Lu, Fan, Wong, Andrea L. A., Sapari, Nur Sabrina, Soong, Richie, Soh, Thomas I. P., Goh, Boon‐Cher, Lee, How‐Sung, Lee, Soo‐Chin

“…Aims Aldo‐ketoreductases have been implicated in the metabolism of doxorubicin. We sought to assess the influence of AKR1C3 genetic variants on doxorubicin…”
Get full text

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer by Wong, Andrea L A, Sundar, Raghav, Wang, Ting-Ting, Ng, Thian-C, Zhang, Bo, Tan, Sing-Huang, Soh, Thomas I P, Pang, Angela S L, Tan, Chee-Seng, Ow, Samuel G W, Wang, Lingzhi, Mogro, Jannet, Ho, Jingshan, Jeyasekharan, Anand D, Huang, Yiqing, Thng, Choon-Hua, Chan, Ching-Wan, Hartman, Mikael, Iau, Philip, Buhari, Shaik A, Goh, Boon-Cher, Lee, Soo-Chin

“…Prolonged anti-angiogenic therapy destroys tumor vasculature, whereas vascular-normalizing doses may enhance intra-tumoral drug delivery. We hypothesize that…”
Get full text

Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction? by Soh, Thomas I P, Yong, Wei Peng

“…In addition to 6-mercaptopurine, 5-fluorouracil and irinotecan, the United States Food and Drug Administration (US FDA) has recently recommended label change…”
Get more information

Correlation of aldo‐ketoreductase ( AKR ) 1C 3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients by Voon, Pei Jye, Yap, Hui Ling, Ma, Cho‐Yee‐Thu, Lu, Fan, Wong, Andrea L. A., Sapari, Nur Sabrina, Soong, Richie, Soh, Thomas I. P., Goh, Boon‐Cher, Lee, How‐Sung, Lee, Soo‐Chin

Get full text